Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases

Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today announced its launch and the closing of a $65...

Related Keywords

Netherlands ,United States ,Naarden ,Noord Holland ,Dmitrij Hristodorov ,Product Service ,Mission Biocapital ,Longwood Fund ,Therapeutics Closes ,Advance Treatments ,Multiple Sclerosis ,Chris Loose ,Netherlands Based Forbion ,Alta Partners ,Dolby Family ,Forbion General Partner Dmitrij Hristodorov ,